We first sent out this alert on 9 March and we’re updating it with some announcements from regulators in other countries and with some of the questions we’ve been asked by our clients. There have been lots of alerts recently on the possible effects of the Coronavirus (COVID-19) but one often overlooked aspect has been Read more »
Cordery Head to Head: Richard Bistrong
In this film, Cordery’s Jonathan Armstrong chats with Richard Bistrong, the CEO of Front-Line Anti-Bribery LLC. Richard is a well known figure in compliance having been voted as one of Compliance Week’s top minds in compliance and having been voted one of the 100 most influential people in business ethics by Ethisphere. He is a Read more »
Everything Compliance – Episode 56 – The Compliance Year under the Trump Administration – Part 2
Welcome to the only roundtable podcast in compliance. In this episode, we end the year with the second of a two-part series on our fan favourite year-end wrap up on the state of compliance under the Trump Administration. Tom and the panel have been following this topic since Trump was elected in 2016 and it is Read more »
Everything Compliance – Episode 54 – The Not Headed to Doral Edition
Welcome to the only roundtable podcast in compliance. Today, we have a quintet of Jay Rosen, Matt Kelly, Sarah Hadden, Jonathan Armstrong and Mike Volkov with a potpourri of topics and commentary on current events from the compliance perspective. Rants and shouts outs follow the commentary for this episode, with one public service announcement from Read more »
Everything Compliance – Episode 52 – The Greenland Purchase Edition
Welcome to the only roundtable podcast in compliance. Today, we have a quartet of Jay Rosen, Matt Kelly, Sarah Hadden and Mike Volkov. Jonathan Armstrong is taking a well deserved break for the next couple of weeks. We focus on the President Trump’s putative initiative to purchase the country of Greenland. We consider the proposed Read more »
Everything Compliance – Episode 51 – The August Reflections Edition
Welcome to the only roundtable podcast in compliance. Today, we have the full quintet of Mike Volkov, Jay Rosen, Matt Kelly, Jonathan Armstrong and Sarah Hadden. Rants and shouts outs follow the commentary for this episode. Jay Rosen takes a look at the recent white paper by ECI President Dr. Pay Harned on the new Read more »
Everything Compliance – Episode 50 – The July Reflections Edition
Welcome to the only roundtable podcast in compliance. Today, we have the full quintet of Mike Volkov, Jay Rosen, Matt Kelly, Jonathan Armstrong and Sarah Hadden. Rants and shouts outs follow the commentary for this episode. Jay Rosen considers why governmental entities other than the federal government benefit from independent integrity monitors in their oversight Read more »
Everything Compliance – Episode 46 – The Justice Department’s 2019 Guidance for FCPA Compliance programs
https://jdsupra-videos.s3.amazonaws.com/ab34139a-ad65-4ebf-940e-00a972479458.mp4 Welcome to the only roundtable podcast in compliance. Today, we have the full quintet of Mike Volkov, Jay Rosen, Matt Kelly, Jonathan Armstrong and our newest colleague, Sarah Hadden. We take on one topic which the panelist explores from their expertise. The topic is the Justice Department’s Evaluation of Corporate Compliance Programs-2019 Guidance which Read more »
Everything Compliance – Episode 44 – The April edition is here
This episode, Tom Fox stands in for Mike Volkov who is on assignment. Episode 44 Jonathan Armstrong discusses a recent presentation he saw by the OECD on some of the key and current numbers on the global fight against bribery and corruption. Jonathan shouts out to Nicola Howard QC for her work on DPAs in Read more »
Everything Compliance – Episode 43 – The Cohen Testifies Edition Part 2
This episode is the conclusion of a special two-part episode. Today, in Episode 43 Jonathan Armstrong and Matt Kelly weigh in on issues that are on their collective minds. Episode 43 Jonathan Armstrong discusses the UK Serious Fraud Office’s conclusion of its investigations into Rolls Royce and GlaxoSmithKline. Matt Kelly considers the continued taunting tweets Read more »